QURE · uniQure N.V.
$48.62
+1.56 (+3.31%)
At close · Aug 14
Market Cap
$3.07B
Shares
63.07M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$48.62
Open$47.06
Day$46.31–48.70
52W close$9.03–70.59
Avg vol 30d1.4M
Short int10.7M · 16.9% float · 6.8d
Short vol46%
Last earningsJul 29, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 29
Up next
Next earnings call
Nov 1, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 29, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+75%
above
Price vs 50-day avg
+20%
above
RSI (14)
69
neutral
MACD trend
Positive
52-week position
64%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+21%
trailing
6-month return
+99%
trailing
YTD return
+103%
this year
Relative strength
+85%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $41 › 200d $28 — 50d above 200d
Institutional flow
Accumulating
+16% holders QoQ · +88 funds added
Insider flow
Distributing
Net -$966.9K over 90 days · 100% sells
Short interest
Rising
16.94% of float · ▲ +3.0% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
257 holders — near 3-yr high, broad support
Squeeze score
87
high risk · 0–100
Fundamentals
Revenue growth
−48%
Y/Y
EPS growth
+30%
Y/Y
Free cash flow
$-178.4M
Balance sheet
$29.5M
net cash
Quant / Vol
risk profile
Volatility
284%
annualized · 1-yr
Max drawdown
−87%
past year
ATR
4.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+75%
Bullish
Price vs 50-day avg
+20%
Bullish
RSI (14)
69
Neutral
MACD trend
Positive
Bullish
52-week position
64%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $41 › 200d $28 — 50d above 200d
Institutional flow
Accumulating
+16% holders QoQ · +88 funds added
Insider flow
Distributing
Net -$966.9K over 90 days · 100% sells
Short interest
Rising
16.94% of float · ▲ +3.0% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
257 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $9
Now $49 · 64%
Range high $71
vs 200-day avg +75%
vs 50-day avg +20%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
QURE
this stock
uniQure N.V.
|
$3.07B | +103.2% | -47.8% | — | 16.9% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| QURE | +4.7% | +20.8% | +98.7% | +11.4% | +103.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +4.3% | +16.4% | +85.0% | +7.5% | +89.3% |
Key facts
CIK
1590560
CUSIP
N90064101
13F (30d)
256 filings
248 filers
Visit website
Investor relations